CN103006877B - Formula for systemic lupus erythematosus treatment drug - Google Patents

Formula for systemic lupus erythematosus treatment drug Download PDF

Info

Publication number
CN103006877B
CN103006877B CN2011102501082A CN201110250108A CN103006877B CN 103006877 B CN103006877 B CN 103006877B CN 2011102501082 A CN2011102501082 A CN 2011102501082A CN 201110250108 A CN201110250108 A CN 201110250108A CN 103006877 B CN103006877 B CN 103006877B
Authority
CN
China
Prior art keywords
radix
root
lupus erythematosus
systemic lupus
pills
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2011102501082A
Other languages
Chinese (zh)
Other versions
CN103006877A (en
Inventor
张志通
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhang Ruihao
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011102501082A priority Critical patent/CN103006877B/en
Publication of CN103006877A publication Critical patent/CN103006877A/en
Application granted granted Critical
Publication of CN103006877B publication Critical patent/CN103006877B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a formula for a systemic lupus erythematosus treatment drug. The formula comprises 10 g of coptis chinensis, 20 g of baikal skullcap root, 15 g of Chinese thorowax root, 10 g of amur corktree bark, 10 g of rheum, 20 g of cape jasmine, 15 g of chrysanthemum, 15 g of szechwan lovage rhizome, 15 g of weeping forsythia fruit, 20 g of kakuda figwort root, 15 g of salvia miltiorrhiza, 30 g of milkvetch root, 15 g of immature bitter orange, 15 g of licorice root, 20 g of rehmannia dride rhizome, 20 g of largehead atractylodes rhizome, 15 g of sappsn wood, 30 g of turtle shell, 30 g of common motherwort herb, 20 g of periostracum cicadae, 20 g of white peony root, 10 g of Chinese ephedra herb, 10 g of agaric, and 15 g of tuckahoe, wherein the drugs are mixed and crushed into 80-100 mesh powder according to a certain ratio, the powder is prepared into pills with a mass of 10 g, people takes 2 pills each time and takes the pills for three times each day, a treatment course is one month, and a good treatment effect can be provided after two treatment course are performed.

Description

The medicament composing prescription of systemic lupus erythematosus
Affiliated technical field
The present invention relates to a kind of medicament composing prescription of systemic lupus erythematosus disease, particularly a kind of medicament composing prescription that utilizes Chinese herbal treatment systemic lupus erythematosus (sle) disease.
Background technology
Systemic lupus erythematosus (sle) is similar to the YIN YANG toxin syndrome of motherland's medical science, and its pathogenesis is damp and hot fire-toxin, and its heresy is filled the air three warmers, up and down inside and outside; Invade the part of the body cavity above the diaphragm housing the heart and lungs, main manifestations is burning hot heresy; In the infringement, the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, main manifestations is damp and hot heresy, modern medicine is thought, the systemic lupus erythematosus (sle) disease is that a kind of autoimmune immunocomplex is sick, often involve whole body a plurality of organs, particularly skin and kidney, the systemic lupus erythematosus (sle) disease does not have preferably Therapeutic Method at present.
Summary of the invention
For systemic lupus erythematosus is sick effectively, the invention provides this sick medicament composing prescription of a kind of very effective treatment.This invention for the plan method for the treatment of of systemic lupus erythematosus (sle) disease is: heat-clearing and toxic substances removing, and blood circulation promoting and blood stasis dispelling, inducing diuresis and reducing edema.
Its prescription is (in grams): Rhizoma Coptidis 10, Radix Scutellariae 20, Radix Bupleuri 15, Cortex Phellodendri 10, Radix Et Rhizoma Rhei 10, Fructus Gardeniae 20, Flos Chrysanthemi 15, Rhizoma Chuanxiong 15, Fructus Forsythiae 15, Radix Scrophulariae 20, Radix Salviae Miltiorrhizae 15, the Radix Astragali 30, Fructus Aurantii Immaturus 15, Radix Glycyrrhizae 15, the Radix Rehmanniae 20, the Rhizoma Atractylodis Macrocephalae 20, Lignum Sappan 15, Carapax Trionycis 30, Herba Leonuri 30, Periostracum Cicadae 20, the Radix Paeoniae Alba 20, Herba Ephedrae 10, Polyporus 10, Poria 15.
Said medicine is mixed in proportion is ground into 80--100 purpose powder, make the pills of 10 grams, each 2 balls, every day 3 times, be a course for the treatment of January, takes two courses for the treatment of, can receive preferably curative effect.
In the side: Radix Scutellariae, Rhizoma Coptidis, Cortex Phellodendri, Fructus Gardeniae, Radix Glycyrrhizae have the effect of clearing away heat-damp and promoting diuresis, in addition, and according to modern study, Fructus Gardeniae, Radix Glycyrrhizae have immunosuppressive action, and Radix Scutellariae has the release that suppresses the allergic inflammation medium, and the Radix Et Rhizoma Rhei bitter cold is rushed down lower, join the Fructus Aurantii Immaturus circulation of qi promoting painful abdominal mass that disappears, damp and hot heresy is separated from stool; Flos Chrysanthemi, Fructus Forsythiae, Radix Scrophulariae all have the effect of Chinese Medicine, can treat the disease of throat, and Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling according to modern study, have the effect of expansion cardiovascular and cerebrovascular vessel, thus the disease at treatment cardiovascular and cerebrovascular vessel position; The Radix Rehmanniae, the Radix Paeoniae Alba, Carapax Trionycis phencyclidine can be prevented the fraud of the impairment of YIN of bitter and cold medicines and drug for invigorating blood circulation and eliminating stasis, the Radix Astragali, Rhizoma Atractylodis Macrocephalae air making-up and spleen enlivening diuretic, the Fructus Aurantii Immaturus circulation of qi promoting painful abdominal mass that disappears, Herba Ephedrae lung qi dispersing harmonizing the functional activities of vital QI, and the Lignum Sappan blood circulation promoting and blood stasis dispelling has the immunosuppressant effect according to modern study.Herba Leonuri, Polyporus, Poria all have the effect of inducing diuresis to remove edema, and the Periostracum Cicadae expelling wind and dampness has immunosuppressant and antianaphylactic effect according to modern study.
This beneficial effect of the invention is: utilize the Chinese herbal medicine of motherland's traditional medicine to carry out reasonable compatibility, treatment cost is lower, and side effect is less, and therapeutic effect is remarkable.
The specific embodiment
The effectiveness of said medicine now is described with 24 routine patients of clinical observation treatment.24 routine patients revise diagnostic criteria according to Americanism damp disease association in 1997 fully, among the patient, man's 3 examples, woman's 21 examples, the shortest person of the course of disease is 2 months, elder is 1 year (the medicine factor that eliminating is associated with the patient of Other diseases and affects the treatment and observe), the patient is by 2 balls, and 3 times on the one taking method is taken 2 courses for the treatment of, the result is according to observations: light-duty (take skin lesion as main) 18 routine patients, cure again recurrence, heavy (also involving other organ-tissue except skin) 6 routine patient's symptoms alleviate to some extent, and rear 6 routine patients take this medicine stable disease after 2 courses for the treatment of again, but can not drug withdrawal, need lifelong after treatment.

Claims (1)

1. the pharmaceutical composition of a systemic lupus erythematosus, it is characterized in that: in grams, Rhizoma Coptidis 10, Radix Scutellariae 20, Radix Bupleuri 15, Cortex Phellodendri 10, Radix Et Rhizoma Rhei 10, Fructus Gardeniae 20, Flos Chrysanthemi 15, Rhizoma Chuanxiong 15, Fructus Forsythiae 15, Radix Scrophulariae 20, Radix Salviae Miltiorrhizae 15, the Radix Astragali 30, Fructus Aurantii Immaturus 15, Radix Glycyrrhizae 15, the Radix Rehmanniae 20, the Rhizoma Atractylodis Macrocephalae 20, Lignum Sappan 15, Carapax Trionycis 30, Herba Leonuri 30, Periostracum Cicadae 20, the Radix Paeoniae Alba 20, Herba Ephedrae 10, Polyporus 10, Poria 15.
CN2011102501082A 2011-08-18 2011-08-18 Formula for systemic lupus erythematosus treatment drug Active CN103006877B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011102501082A CN103006877B (en) 2011-08-18 2011-08-18 Formula for systemic lupus erythematosus treatment drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011102501082A CN103006877B (en) 2011-08-18 2011-08-18 Formula for systemic lupus erythematosus treatment drug

Publications (2)

Publication Number Publication Date
CN103006877A CN103006877A (en) 2013-04-03
CN103006877B true CN103006877B (en) 2013-10-30

Family

ID=47956340

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011102501082A Active CN103006877B (en) 2011-08-18 2011-08-18 Formula for systemic lupus erythematosus treatment drug

Country Status (1)

Country Link
CN (1) CN103006877B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103933383A (en) * 2014-03-20 2014-07-23 毛杰 Traditional Chinese medicine for treating systemic lupus erythermatosus
CN107320613A (en) * 2017-07-14 2017-11-07 高学哲 A kind of systemic lupus erythematosus powder and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088788A (en) * 1992-12-26 1994-07-06 史宝印 A kind of lupus for the treatment of lupus erythematosus is loose and compound method
CN1422643A (en) * 2001-12-06 2003-06-11 高大海 Oral pill for treating lupus erythematosus
CN1488372A (en) * 2002-10-09 2004-04-14 赵洪起 Chinese medicine formual for treating heptitis
CN101637585A (en) * 2009-08-20 2010-02-03 卢速江 Chinese herbal preparation for treating posirasis and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088788A (en) * 1992-12-26 1994-07-06 史宝印 A kind of lupus for the treatment of lupus erythematosus is loose and compound method
CN1422643A (en) * 2001-12-06 2003-06-11 高大海 Oral pill for treating lupus erythematosus
CN1488372A (en) * 2002-10-09 2004-04-14 赵洪起 Chinese medicine formual for treating heptitis
CN101637585A (en) * 2009-08-20 2010-02-03 卢速江 Chinese herbal preparation for treating posirasis and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
尚志华,等.浅述系统性红斑狼疮中药临床的几个问题.《光明中医》.2003,第18卷(第109期),第52-54页. *
范丽英,等.皮肤红斑狼疮中医药治疗现状.《中国中西医结合皮肤性病学杂志》.2008,第7卷(第4期),第260-263页. *

Also Published As

Publication number Publication date
CN103006877A (en) 2013-04-03

Similar Documents

Publication Publication Date Title
CN102274361A (en) Anticancer medicinal composition and preparation method of decoction thereof
CN103784820A (en) Traditional Chinese medicine formula for treating cariac blood stasis type coronary heart disease
CN103860699B (en) A kind of pharmaceutical composition for effecting a radical cure three-hypers
CN100400094C (en) Traditional Chinese medicine for treating hepatitis B and its preparing process
CN104383115A (en) Traditional Chinese medicine preparation for treating coronary heart disease and preparation method of traditional Chinese medicine preparation
CN101987138A (en) Chinese medicinal preparation for treating impotence
CN102247479B (en) Antitumor strong medicine and preparation method thereof
CN103656122B (en) Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof
CN101518640A (en) Chinese traditional medicine prescription for treating tumor
CN103006877B (en) Formula for systemic lupus erythematosus treatment drug
CN1186687A (en) Cancer preventing curing medicine series and its preparation
CN101444613A (en) Traditional Chinese medicine formula for treating chronic hepatitis
CN105902793A (en) Traditional Chinese medicine for treatment of coronary heart disease
CN101991797A (en) Medicine formula for treating Behcet's disease
CN101757206A (en) Chinese medicine preparation for treating chronic colitis
CN105250954B (en) A kind of Chinese medicine for treating IBS and preparation method thereof
CN103610796A (en) Traditional Chinese medicinal composition for treating exfoliative inflammation of lips
CN103721082A (en) Traditional Chinese medicinal composition for treating scapulohumeral periarthritis
CN103495130B (en) Traditional Chinese medicine composition for treating asthma
CN101485823B (en) Medicament for treating lung cancer and preparation method thereof
CN101199687A (en) Medicament compound for treating chronic prostatitis and preparing method thereof
CN102949684B (en) Medicine formula for treating rheumatoid arthritis
CN102949658B (en) Drug formula for treating hepatitis
CN102949605B (en) Medicine formula for treating non-specificity ulcerative colitis
CN102114211A (en) Chinese herbal medicine for treating hepatopathy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20210319

Address after: No.42-1, sangyuan Road, Licheng District, Jinan City, Shandong Province, 250100

Patentee after: Liu Jinbo

Address before: 734200 community 9, kangzhai village, Xinhua Township, Linze County, Gansu Province

Patentee before: Zhang Zhitong

TR01 Transfer of patent right
DD01 Delivery of document by public notice
DD01 Delivery of document by public notice

Addressee: Liu Jinbo

Document name: Notification of eligibility

DD01 Delivery of document by public notice
DD01 Delivery of document by public notice

Addressee: Liu Jinbo

Document name: Notification of eligibility

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20210520

Address after: 650000 Room 501, Unit 1, Building 162 Yongan Road, Taihe Street Office, Guandu District, Kunming City, Yunnan Province

Patentee after: Zhang Ruihao

Address before: No.42-1, sangyuan Road, Licheng District, Jinan City, Shandong Province, 250100

Patentee before: Liu Jinbo